These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8285171)
1. [Cancer immunotherapy by murine bladder cancer cells transfected with mouse interferon-gamma gene]. Hashimura T; Hiura M; Yoshida O; Teramura Y; Kuribayashi K; Watanabe Y Hinyokika Kiyo; 1993 Dec; 39(12):1205-8. PubMed ID: 8285171 [TBL] [Abstract][Full Text] [Related]
2. Induction of specific anti-tumour immunity by interferon-gamma gene-transferred murine bladder carcinoma MBT-2. Hiura M; Hashimura T; Watanabe Y; Kuribayashi K; Yoshida O Folia Biol (Praha); 1994; 40(1-2):49-61. PubMed ID: 7958064 [TBL] [Abstract][Full Text] [Related]
3. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma. Shiau AL; Lin CY; Tzai TS; Wu CL Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496 [TBL] [Abstract][Full Text] [Related]
4. [Gene therapy by in vivo interferon-gamma gene transfer to murine bladder tumor]. Hashimura T; Ueda T; Hiura M; Yoshida O; Kawabata K; Watanabe Y; Takami M Hinyokika Kiyo; 1997 Nov; 43(11):809-13. PubMed ID: 9436027 [TBL] [Abstract][Full Text] [Related]
5. Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity. Yanagihara K; Seyama T; Watanabe Y Nat Immun; 1994; 13(2-3):102-12. PubMed ID: 8173232 [TBL] [Abstract][Full Text] [Related]
6. Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector. Kimura T; Ohashi T; Kikuchi T; Kiyota H; Eto Y; Ohishi Y Cancer Gene Ther; 2003 Nov; 10(11):833-9. PubMed ID: 14605669 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse gamma-interferon complementary DNA. Nishihara K; Miyatake S; Sakata T; Yamashita J; Kikuchi H; Kawade Y; Zu Y; Namba Y; Hanaoka M; Watanabe Y Cancer Res; 1988 Sep; 48(17):4730-5. PubMed ID: 3136912 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of simultaneous transfer of interleukin-12 and interleukin-18 genes and its mechanism in a mouse bladder cancer model. Hikosaka S; Hara I; Miyake H; Hara S; Kamidono S Int J Urol; 2004 Aug; 11(8):647-52. PubMed ID: 15285756 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response. Furukawa J; Hara I; Nagai H; Yao A; Oniki S; Fujisawa M J Urol; 2006 Sep; 176(3):1198-203. PubMed ID: 16890725 [TBL] [Abstract][Full Text] [Related]
10. [A novel experimental approach to immunotherapy against malignant brain tumor with the mouse IFN-gamma gene transfer]. Nishihara K Nihon Geka Hokan; 1989 Jan; 58(1):18-42. PubMed ID: 2508589 [TBL] [Abstract][Full Text] [Related]
11. Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria. Kuromatsu I; Matsuo K; Takamura S; Kim G; Takebe Y; Kawamura J; Yasutomi Y Cancer Gene Ther; 2001 Jul; 8(7):483-90. PubMed ID: 11498769 [TBL] [Abstract][Full Text] [Related]
12. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141 [TBL] [Abstract][Full Text] [Related]
14. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154. Loskog A; Tötterman TH; Böhle A; Brandau S Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026 [TBL] [Abstract][Full Text] [Related]
15. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Gansbacher B; Bannerji R; Daniels B; Zier K; Cronin K; Gilboa E Cancer Res; 1990 Dec; 50(24):7820-5. PubMed ID: 2123742 [TBL] [Abstract][Full Text] [Related]
16. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells. Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816 [TBL] [Abstract][Full Text] [Related]
17. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. Porgador A; Bannerji R; Watanabe Y; Feldman M; Gilboa E; Eisenbach L J Immunol; 1993 Feb; 150(4):1458-70. PubMed ID: 8432988 [TBL] [Abstract][Full Text] [Related]
18. Transfection of interferon-gamma gene in animal tumors--a model for local cytokine production and tumor immunity. Watanabe Y Semin Cancer Biol; 1992 Feb; 3(1):43-6. PubMed ID: 1643293 [TBL] [Abstract][Full Text] [Related]
19. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells. Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794 [TBL] [Abstract][Full Text] [Related]